Stockreport

Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

Structure Therapeutics Inc.  (GPCR) 
PDF Topline GSBR-1290 Phase 2a 12-week obesity data on track for June 2024 Phase 2b study in obesity expected to begin as planned in the fourth quarter 2024 Plan to initia [Read more]